Safety profile of protein kinase inhibitors in rheumatoid arthritis: systematic review and meta-analysis.
about
Emerging Roles of the Mitogen and Stress Activated Kinases MSK1 and MSK2Impact of tofacitinib on patient outcomes in rheumatoid arthritis - review of clinical studiesSystematic review and meta-analysis of serious infections with tofacitinib and biologic disease-modifying antirheumatic drug treatment in rheumatoid arthritis clinical trialsA Novel Triazolopyridine-Based Spleen Tyrosine Kinase Inhibitor That Arrests Joint Inflammation[Intracellular targets : current data on effectiveness and safety profile].Targeting the tyrosine kinase signalling pathways for treatment of immune-mediated glomerulonephritis: from bench to bedside and beyond.Advances in kinase inhibition: treating rheumatic diseases and beyond.Spleen tyrosine kinase inhibitors for rheumatoid arthritis: where are we now?The effectiveness of tofacitinib, a novel Janus kinase inhibitor, in the treatment of rheumatoid arthritis: a systematic review and meta-analysisEfficacy and safety of tofacitinib in the treatment of rheumatoid arthritis: a systematic review and meta-analysis.The effect of RO3201195 and a pyrazolyl ketone P38 MAPK inhibitor library on the proliferation of Werner syndrome cells.Common γ-chain blocking peptide reduces in vitro immune activation markers in HTLV-1-associated myelopathy/tropical spastic paraparesis.Rheumatoid factors: clinical applications.Clinical utility of the oral JAK inhibitor tofacitinib in the treatment of rheumatoid arthritis.Emerging immunotherapies for rheumatoid arthritis.Proteasome inhibitors as experimental therapeutics of autoimmune diseases.Epidermolysis Bullosa Acquisita: From Pathophysiology to Novel Therapeutic Options.Benefit and Risk of Tofacitinib in the Treatment of Rheumatoid Arthritis: A Focus on Herpes Zoster.Do antiepileptic drugs increase the risk of infectious diseases? A meta-analysis of placebo-controlled studies.Fostamatinib, an oral spleen tyrosine kinase inhibitor, in the treatment of rheumatoid arthritis: a meta-analysis of randomized controlled trials.Oral janus kinase inhibitor for the treatment of rheumatoid arthritis: tofacitinib.European perspective on the management of rheumatoid arthritis: clinical utility of tofacitinib.Inhibitory effect of JAK inhibitor on mechanical stress-induced protease expression by human articular chondrocytes.Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients?Chronic Pain in Inflammatory Arthritis: Mechanisms, Metrology, and Emerging Targets-A Focus on the JAK-STAT Pathway.
P2860
Q26744783-6579C7AD-E760-420F-A917-EEDB7E39BC60Q26772850-0A4FB4E2-83F9-4CAA-91DD-2AEFD362628CQ28084309-52B3A21F-0407-4CAC-908A-9525A376A235Q28552367-9E1848DC-149B-4066-9B10-EF86DB53A48CQ30689247-61332135-8D9D-4757-BA8B-897955328A3AQ33620537-07F12BA2-A171-4945-A97F-8B24844BC074Q33930795-0DCEA6F7-DECE-4659-AE4F-B7D987AD9ED0Q34409073-A6B80BB8-F84C-422B-96C1-1ADA82A668AFQ34858352-3A089ADE-C9CB-4BA1-8A3E-9CE088BED1B5Q35020811-5AB9B203-5710-418B-AB37-67D7E0F58526Q35854103-34E51CCE-0175-4150-AC0F-87000CECD45FQ36055527-0AD64E86-3307-4712-9029-0B24219E96B8Q37353700-2DFF1291-7855-4692-9F41-0CA813792185Q38181051-4CAC5138-85BA-4EA2-A1C7-0A6AA470E2B1Q38188862-46B6C882-EA5B-4218-861A-078EC35EF985Q38427697-BE04BBC9-672A-4421-8F06-27C2DF6E1617Q38695599-EB52FCC3-496F-43D7-A24E-B614E4A97526Q38837769-B2415A53-0E8C-46C7-857E-51BD514704E4Q40267179-7F3C0563-4879-4B9B-B58A-BA6DFD8E1D59Q40699579-92F60F06-F677-4C25-9D15-3AA503F8BFE1Q42537908-00ECD84C-4FE1-4F4D-A09F-779D7593D4D8Q47338654-E267AF13-C031-43D5-8463-789BBFD6C1D3Q48018323-C8DFF268-9DAC-487E-9F52-7CB6A7C17F2BQ54977224-7A599121-771E-4566-BE05-9F60E8BBC7BFQ55027042-32079558-D571-44C7-9161-005CB7E70166
P2860
Safety profile of protein kinase inhibitors in rheumatoid arthritis: systematic review and meta-analysis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Safety profile of protein kina ...... atic review and meta-analysis.
@ast
Safety profile of protein kina ...... atic review and meta-analysis.
@en
Safety profile of protein kina ...... atic review and meta-analysis.
@nl
type
label
Safety profile of protein kina ...... atic review and meta-analysis.
@ast
Safety profile of protein kina ...... atic review and meta-analysis.
@en
Safety profile of protein kina ...... atic review and meta-analysis.
@nl
prefLabel
Safety profile of protein kina ...... atic review and meta-analysis.
@ast
Safety profile of protein kina ...... atic review and meta-analysis.
@en
Safety profile of protein kina ...... atic review and meta-analysis.
@nl
P2860
P1476
Safety profile of protein kina ...... atic review and meta-analysis.
@en
P2093
Eva Salgado
Juan J Gomez-Reino
P2860
P304
P356
10.1136/ANNRHEUMDIS-2012-203116
P407
P577
2013-04-18T00:00:00Z